IRIS
MISSALE, Gabriele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.633
AS - Asia 7.499
EU - Europa 4.336
SA - Sud America 1.162
AF - Africa 438
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 8
Totale 21.092
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.404
SG - Singapore 2.764
CN - Cina 1.725
VN - Vietnam 1.131
IT - Italia 1.016
BR - Brasile 909
IE - Irlanda 828
SE - Svezia 668
HK - Hong Kong 576
DE - Germania 399
BD - Bangladesh 388
FR - Francia 382
ZA - Sudafrica 295
NL - Olanda 230
FI - Finlandia 209
TR - Turchia 205
IN - India 150
CA - Canada 134
GB - Regno Unito 118
RU - Federazione Russa 112
AR - Argentina 98
UA - Ucraina 80
KR - Corea 74
JP - Giappone 67
AT - Austria 65
IQ - Iraq 65
MX - Messico 52
ID - Indonesia 44
PH - Filippine 40
CI - Costa d'Avorio 39
PL - Polonia 36
CO - Colombia 35
PK - Pakistan 35
VE - Venezuela 33
BE - Belgio 32
EC - Ecuador 28
ES - Italia 28
UZ - Uzbekistan 28
TH - Thailandia 24
KE - Kenya 22
MA - Marocco 22
CZ - Repubblica Ceca 21
TW - Taiwan 19
CL - Cile 17
LT - Lituania 17
MY - Malesia 17
PY - Paraguay 17
AE - Emirati Arabi Uniti 13
AU - Australia 13
AZ - Azerbaigian 12
EG - Egitto 12
GR - Grecia 12
JO - Giordania 11
RO - Romania 11
SA - Arabia Saudita 11
UY - Uruguay 11
IL - Israele 10
OM - Oman 10
IR - Iran 9
KZ - Kazakistan 9
PE - Perù 9
DK - Danimarca 8
PS - Palestinian Territory 8
TN - Tunisia 8
AL - Albania 7
CH - Svizzera 7
DZ - Algeria 7
KH - Cambogia 7
NP - Nepal 7
BG - Bulgaria 6
BY - Bielorussia 6
CR - Costa Rica 6
JM - Giamaica 6
LV - Lettonia 6
PA - Panama 6
AM - Armenia 5
DO - Repubblica Dominicana 5
ET - Etiopia 5
EU - Europa 5
GE - Georgia 5
GT - Guatemala 5
KG - Kirghizistan 5
LU - Lussemburgo 5
RS - Serbia 5
AO - Angola 4
BO - Bolivia 4
HN - Honduras 4
LB - Libano 4
LY - Libia 4
PT - Portogallo 4
QA - Qatar 4
TT - Trinidad e Tobago 4
BH - Bahrain 3
EE - Estonia 3
HR - Croazia 3
HU - Ungheria 3
MN - Mongolia 3
SI - Slovenia 3
XK - ???statistics.table.value.countryCode.XK??? 3
BN - Brunei Darussalam 2
Totale 21.046
Salva come PNG Salva come JPEG
Città #
Singapore 1.412
Ashburn 1.023
Dublin 828
San Jose 806
Chandler 620
Santa Clara 579
Dallas 569
Hong Kong 540
Beijing 397
Ho Chi Minh City 323
Hanoi 291
Johannesburg 274
Boardman 269
Parma 237
New York 229
Los Angeles 212
Ann Arbor 201
Dearborn 191
Shanghai 176
Lauterbourg 156
Princeton 147
Izmir 132
Nanjing 120
Munich 116
Wilmington 99
São Paulo 98
Milan 91
Hefei 88
Grafing 77
Council Bluffs 74
Helsinki 74
Jacksonville 73
Buffalo 70
Columbus 65
Moscow 59
Jinan 55
Rome 55
Seoul 54
Haiphong 53
Tokyo 53
Shenyang 51
Vienna 51
Des Moines 50
Da Nang 49
Toronto 47
Chicago 46
Bremen 43
Seattle 43
Frankfurt am Main 41
Abidjan 39
Bologna 37
Tianjin 37
Turku 36
Montreal 35
Bengaluru 34
Rio de Janeiro 34
The Dalles 34
Guangzhou 32
Hebei 32
Kunming 31
Nuremberg 31
Kocaeli 30
Warsaw 30
Nanchang 28
London 27
Orem 26
Naples 25
Reggio Emilia 25
Brooklyn 24
Brussels 24
Changsha 24
Jakarta 24
Stockholm 24
Phoenix 23
Redmond 23
Tashkent 23
Ardea 22
Houston 21
Jiaxing 21
Zhengzhou 21
Belo Horizonte 20
Amsterdam 19
Atlanta 19
Chennai 19
Denver 19
Dhaka 19
Hải Dương 18
Mexico City 18
Nairobi 18
Norwalk 18
San Mateo 18
Baghdad 17
Boston 17
Hangzhou 17
Salvador 17
Düsseldorf 16
Istanbul 16
San Francisco 16
Fairfield 15
Fremont 15
Totale 12.635
Salva come PNG Salva come JPEG
Nome #
A novel enhancing effect of SARS-CoV-2 mutations on anti-viral CD8 T cell responses 318
FUNCTIONAL AND TRANSCRIPTIONAL RESTORATION OF EXHAUSTED VIRUS-SPECIFIC T LYMPHOCYTES FROM PATIENTS WITH CHRONIC HEPATITIS B 302
Role of immunoglobulin G fragment C receptor polymorphism-mediatedantibody-dependant1. cellular cytotoxicity in colorectal cancer treated withcetuximab therapy. Pharmacogenomics J. 298
Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection 283
HBcrAg values may predict virological and immunological responses to pegIFN-α in NUC-suppressed HBeAg-negative chronic hepatitis B 256
Ammonium Production and Glutamine-Addiction of Myeloma Cells: New Attractive Targets in Multiple Myeloma 221
Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target 220
CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells 218
Anti-Viral Intrahepatic T-Cell Responses can be Restored by Blocking Programmed Death-1 Pathway in Chronic Hepatitis B 211
A simplified sars-cov-2 pseudovirus neutralization assay 211
Activation of Natural Killer Cells During Acute Infection With Hepatitis C Virus 203
L-Asparaginase and Inhibitors of Glutamine Synthetase DiscloseGlutamine Addiction of Beta-Catenin-Mutated Human HepatocellularCarcinoma Cells 186
Natural heteroclitic-like peptides are generated by SARS-CoV-2 mutations 185
Pathogenetic Mechanisms of T Cell Dysfunction in Chronic HBV Infection and Related Therapeutic Approaches 185
The circulating pool of functionally competent NK and CD8+ cells predicts the outcome of anti-PD1 treatment in advanced NSCLC 179
Metabolic regulation of the HBV-specific T cell function 176
Deregulated intracellular pathways define novel molecular targets for HBV-specific CD8 T cell reconstitution in chronic hepatitis B 174
Corrigendum: CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells (Frontiers in Oncology, (2022), 12, (942341), 10.3389/fonc.2022.942341) 170
Energy metabolism and cell motility defect in NK-cells from patients with hepatocellular carcinoma 166
Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B 162
DEPENDENCE ON GLUTAMINE UPTAKE OF MYELOMA CELLS DELINEATES A NEW ATTRACTIVE THERAPEUTIC STRATEGY 159
[68Ga]Nivolumab: a novel PET tracer to detect PD-1 expressing tumors 158
Changes in hepatocellular carcinoma aggressiveness characteristics with an increase in tumor diameter 157
Are Anti-TNF-α Agents Safe for Treating Psoriasis in Hepatitis C Virus Patients with Advanced Liver Disease? Case Reports and Review of the Literature 156
The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: A multicenter cohort study 156
1929O Soluble PD-L1 and circulating CD8+PD1+ and NK cells enclose a highly prognostic and predictive immune effector score in immunotherapy treated NSCLC patients 155
Resolution of late-onset heart and liver failures after reversion of jejuno-ileal bypass: a case report 155
Correlation between LDH levels and response to sorafenib in HCC patients: An analysis of the ITA.LI.CA database 155
Natural killer cell phenotype modulation and natural killer/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis B 155
Cytotoxic T Cell response to Melanoma Associated Antigens (MAGE) in patients with Hepatocellular Carcinoma 153
Role of immunoglobulin G fragment C receptor polymorphism-mediated antibody-dependant cellular cytotoxicity in colorectal cancer treated with cetuximab therapy 153
Clinico-Immunological Profile of a 67-Year-Old Woman Affected by HER2-Positive Breast Cancer and Autoimmune Dermatomyositis 153
Antibody responses to hepatitis C virus hypervariable region 1: Evidence for cross-reactivity and immune-mediated sequence variation 152
Acute phase HBV-specific T cell responses associated with HBV persistence after HBV/HCV coinfection 151
Antibody responses to hepatitis C virus hypervariable region 1: evidence for cross-reactivity and immune-mediated sequence variation 150
Antiviral CD8-mediated responses in chronic HCV carriers with HBV superinfection 150
Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: Implications for its clinical use 150
HBV immune-therapy: From molecular mechanisms to clinical applications 149
Oral lichen planus pathogenesis: A role for the HCV-specific cellular immune response. 146
Immune gene expression profile in hepatocellular carcinoma and surrounding tissue predicts time to tumor recurrence 146
The good and the bad of natural killer cells in virus control: Perspective for anti-HBV therapy 146
Soluble PD-L1 and Circulating CD8+PD-1+ and NK Cells Enclose a Prognostic and Predictive Immune Effector Score in Immunotherapy Treated NSCLC patients 145
Ex vivo characterization of tumor-derived melanoma antigenencoding gene-specific CD8 1 cells in patientswith hepatocellular carcinoma 143
T cell regulation in HBV-related chronic liver disease 143
[Surgical risks for cirrhotic patients] 140
Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitro 139
Glutamine depletion by crisantaspase hinders the growth of human hepatocellular carcinoma xenografts 139
Circulating immune-profile as predictor of outcome in advanced NSCLC patients treated with Nivolumab 138
Vascular liver injury mimicking an intrahepatic cholangiocarcinoma in a COVID-19 patient 137
Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma 137
Early kinetics of innate and adaptive immune responses during hepatitis B virus infection 135
The changing scenario of hepatocellular carcinoma in Italy: an update 135
Antigen Load and T Cell Function: A Challenging Interaction in HBV Infection 134
Unraveling the multifaceted nature of cd8 t cell exhaustion provides the molecular basis for therapeutic t cell reconstitution in chronic hepatitis b and c 134
Expression of pERK and VEGFR-2 in advanced hepatocellular carcinoma and resistance to sorafenib treatment 133
Role of innate and adaptive immunity in the efficacy of anti-HER2 monoclonal antibodies for HER2-positive breast cancer 132
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: A multicentre study 132
Targeting Stress Sensor Kinases in Hepatocellular Carcinoma-Infiltrating Human NK Cells as a Novel Immunotherapeutic Strategy for Liver Cancer 131
What Is the Current Status of Hepatitis B Virus Viro-Immunology? 130
Randomized, open-label, phase II, biomarker study of immune-mediated mechanism of action of neoadjuvant subcutaneous trastuzumab in patients with locally advanced, inflammatory, or early HER2-positive breast cancer-Immun-HER trial (GOIRC-01-2016) 129
Utility of Tumor Burden Score to Stratify Prognosis of Patients with Hepatocellular Cancer: Results of 4759 Cases from ITA.LI.CA Study Group 128
Simultaneous Combination of the CDK4/6 Inhibitor Palbociclib With Regorafenib Induces Enhanced Anti-tumor Effects in Hepatocarcinoma Cell Lines 128
Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection: effect of viremia levels and antiviral treatment. 127
Application of the Intermediate-Stage Subclassification to Patients with Untreated Hepatocellular Carcinoma 124
Infection of circulating and liver infiltrating T cells by hepatitis C virus of different subtypes 123
Cytotoxic T Cell response to Melanoma Associated Antigens (MAGE) in patients with Hepatocellular Carcinoma. 123
Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/neu-Positive Metastatic Breast Cancer. 123
Neoplastic macrovascular invasion represents an independent risk factor for dismal survival in sorafenib treatment for hepatocellular carcinoma 122
AISF position paper on HCV in immunocompromised patients 122
The evolutionary scenario of hepatocellular carcinoma in Italy: an update 121
Functional reconstitution of HBV-specific CD8 T cells by in vitro polyphenol treatment in chronic hepatitis B 121
Head-injured subjects aged over 50 years: correlations between variables of trauma and neuropsychologial follow-up 120
Integrated prognostication of intrahepatic cholangiocarcinoma by contrast-enhanced computed tomography: the adjunct yield of radiomics 119
Clinical and hematologic parameters address the outcomes of non-small-cell lung cancer patients treated with nivolumab 118
FluoroSpot assay to analyze SARS-CoV-2-specific T cell responses 117
COMPOSTO E COMPOSIZIONE PER IL RIPRISTINO METABOLICO E FUNZIONALE DEI LINFOCITI NK NELL’EPATOCARCINOMA E RELATIVO METODO 115
Rise and fall of HCV-related hepatocellular carcinoma in Italy: A long-term survey from the ITA.LI.CA centres 115
Intratumor Regulatory Noncytotoxic NK Cells in Patients with Hepatocellular Carcinoma 115
TRANSCRIPTOME ANALYSIS OF EXHAUSTED VIRUS-SPECIFIC CD8 T CELLS IN CHRONIC HBV INFECTION IDENTIFIES PROFOUND METABOLIC AND FUNCTIONAL CELL DEFECTS 114
Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen 113
Fine specificity of the human T cell response to hepatitis B virus core antigen 112
Immunoglobulin G fragment C receptor polymorphisms and response to trastuzumab-based treatment in patients with HER-2/NEU-positive metastatic breast cancer 112
The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro 112
Metabolic disorders across hepatocellular carcinoma in Italy 110
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma 109
Conserved hepatitis C virus sequences are highly immunogenic for CD4+ T cells: Implications for vaccine development 109
Etanercept in the treatment of psoriasis and psoriathic arthritis with concomitant hepatitis C virus infection: clinical and virological study in three patients 108
Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection 108
Immune pathogenesis of hepatitis B 107
Comparative pathogenesis of HBV and HCV 107
Divergent PD-1 expression in tissue and circulating CD8 lymphocytes defines an immune profile predictive of the response to nivolumab in advanced NSCLC 106
Oral lichen planus infiltrating T-cells:a Pathogenetic role for HCV-specific T cell responses? 106
Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C 106
Rifaximin versus neomycin on hyperammoniemia in chronic portal systemic encephalopathy of cirrhotics. A double-blind, randomized trial 106
Monofocal hepatocellular carcinoma: How much does size matter? 105
In reply 104
The surgical risk in cirrhosis of the liver 104
Utility-based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: A multicenter cohort study using the alpha-fetoprotein model as a survival predictor 102
The Characteristics of the Cell-Mediated Immune Response Identify Different Profiles of Occult Hepatitis B Virus Infection 101
Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV 101
Totale 14.658
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.920
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.920
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202135 0 0 0 0 0 0 0 0 0 0 0 35
2021/2022727 19 21 26 53 47 91 38 54 36 21 44 277
2022/20232.802 318 250 185 172 168 298 53 157 988 25 116 72
2023/20241.260 72 122 42 57 113 292 85 88 46 74 92 177
2024/20254.417 91 221 279 233 492 548 224 198 576 421 361 773
2025/20269.829 830 877 1.142 850 1.268 489 1.017 311 1.248 743 690 364
Totale 21.393